Amphastar Pharmaceuticals Inc expected to post earnings of 21 cents a share - Earnings Preview

Amphastar Pharmaceuticals,

06/08/2021 23:05

* Amphastar Pharmaceuticals Inc  AMPH.OQ   AMPH.O  is expected
to show a rise in quarterly revenue when it reports results on
August 9. 
* The Rancho Cucamonga, California-based company is expected to
report   a 18.1% increase in revenue to $101.379 million from
$85.81 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Amphastar
Pharmaceuticals Inc is for earnings of 21 cents per share. For
the same quarter last year, the company reported earnings of 16
cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $21.5​, about 5.3% above​ its last
closing price of $20.35. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  0.18        0.18       0.27      Beat    46.5
 Dec. 31 2020              0.14       0.16      Beat    16.7
 Sep. 30 2020  0.15        0.14       0.15      Beat    6.8​
 Jun. 30 2020  0.14        0.14       0.16      Beat    17.9
 Mar.          0.08​       0.09       0.17      Beat    97.7​
 31​ 2020​                                              
 Dec. 31 2019  -0.01       0.07       0.07      Met     -5.6​
 Sep. 30 2019  0.07        0.07       0.10      Beat    49.6
 Jun. 30 2019  0.06        0.03       0.08      Beat    134.1
 This summary was machine generated August 6 at 22:05 GMT.  All
figures in US dollars unless otherwise stated